SRDX | tickerfilter.com

Fundamental analysis

33%

Profitability 10%

Dept financing 33%

Liquidity 69%

Performance 48%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.78%

1 Month

1.87%

3 Months

-13.07%

6 Months

-17.09%

1 Year

20.31%

2 Year

35.28%

Key data

Stock price

$31.10

P/E Ratio

0.00

DAY RANGE

$29.06 - $31.28

EPS

$0.04

52 WEEK RANGE

$26.54 - $42.43

52 WEEK CHANGE

$21.06

MARKET CAP

567.310 M

YIELD

N/A

SHARES OUTSTANDING

14.267 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-30-2025

BETA

0.40

PUBLIC FLOAT

AVERAGE 10 VOLUME

$74,601

AVERAGE 30 VOLUME

$96,234

Company detail

CEO: Gary R. Maharaj
Region: US
Website: surmodics.com
Employees: 450
IPO year: 1998

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Surmodics, Inc. provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices. The IVD segment designs, develops, and manufactures component products and technologies for diagnostics. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

SRDX - SURMODICS INC